Careseng 1370 for Chemotherapy-Induced Myelosuppression

NCT03692780 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped At sponsor's discretion

Conditions

Chemotherapy-Induced Myelosuppression

Interventions

DRUG: Careseng 1370
DRUG: Placebo

Sponsor

Careseng Biotech Co., Ltd.